Coroplast Group Partners with OpenText to Meet Poland's E-Invoicing Mandates

OpenText's Business Cloud and E-Invoicing Platform simplifies e-invoicing for global mid-sized business

OpenText™ (NASDAQ: OTEX), (TSX: OTEX), the information company, today announced that it has been selected by Coroplast Group, a leading manufacturer in the fields of Technical Adhesive Tapes, Wires & Cables, and Wire Harnesses, as its e-invoicing provider for Poland . OpenText's e-invoicing solutions will empower the growing global company to confidently manage mandatory governmental requirements in Poland partnering toward the goals of a seamless connection to the Polish KSeF-portal and compliance with the local mandate.

OpenText logo (PRNewsfoto/Open Text Corporation)

As part of the European Commission's universal e-invoicing mandate (ViDA), businesses operating in Poland must comply and establish the necessary infrastructure. With OpenText as its e-invoicing provider, Coroplast Group can feel confident in its compliance while also reaping the benefits of the platform, such as streamlined document processing, real-time invoice information for business management, and expedited VAT returns.

"As our company grows worldwide, it can be tricky to understand and follow the various mandates in each new market," said Astrid Hasen , Teamlead SAP FI/CO at Coroplast Group. "With OpenText's help, we are confident that we now meet the electronic invoicing requirements not only in Poland but also in other countries. This ensures not only our compliance but also provides our teams access to a world-class user-friendly invoicing platform that makes our processes more efficient."

Coroplast Group's decision to partner with OpenText is based on the robust capabilities of OpenText's Business Network Cloud Foundation. This innovative solution offers a lean and adaptable approach, especially suited for companies venturing into managed services. This strategic move aligns seamlessly with the evolving landscape of digital transformation, empowering mid-sized companies like Coroplast Group to efficiently manage their electronic data interchange (EDI) and e-invoicing processes.

"As a leader in supply chain optimization, we are committed to helping businesses meet the growing global e-invoicing mandates," said Muhi Majzoub, EVP & Chief Product Officer at OpenText. "In today's fast-paced global economy, complying with ever-changing regulations can be a challenging and time-consuming task for many companies. OpenText is here to take the pressure off businesses by offering trustworthy and flexible e-invoicing solutions. Our goal is not only to meet regulatory requirements but also to provide valuable real-time insights that will revolutionize the future of business."

OpenText's Business Cloud and E-Invoicing Platform is a cloud-based electronic invoicing solution that helps businesses reduce operational costs,  comply with regulations, and increase process efficiency. The platform offers a broad set of solutions to support electronic invoicing, including OpenText™ Active Invoices with Compliance and OpenText™ Business Network Cloud Foundation. These solutions simplify e-Invoicing compliance to meet regulations in more than 48 countries and provide B2B integration for small and mid-sized businesses. With OpenText's Business Cloud and E-Invoicing Platform, businesses can reduce the time spent on invoicing, minimize invoicing errors, expedite payment, and enhance customer satisfaction.

Additional Resources:

To learn more about OpenText™ Business Network Cloud Enterprise read here .

About Coroplast Group

The Coroplast Group is a globally successful, independent, family-run company managed in the third generation by Natalie Mekelburger as President and CEO. Over its 95-year history, the company has evolved from a local manufacturer of electrical insulation materials to a global player and technology leader in the fields of Technical Adhesive Tapes, Wires & Cables, and Wire Harnesses. Visit our website to learn more.

About OpenText  
OpenText, The Information Company™, enables organizations to gain insight through market leading information management solutions, powered by OpenText Cloud Editions. For more information about OpenText (NASDAQ: OTEX, TSX: OTEX) visit opentext.com .

Connect with us:
OpenText CEO Mark Barrenechea's blog
  Twitter | LinkedIn

Certain statements in this press release may contain words considered forward-looking statements or information under applicable securities laws. These statements are based on OpenText's current expectations, estimates, forecasts and projections about the operating environment, economies, and markets in which the company operates. These statements are subject to important assumptions, risks and uncertainties that are difficult to predict, and the actual outcome may be materially different. OpenText's assumptions, although considered reasonable by the company at the date of this press release, may prove to be inaccurate and consequently its actual results could differ materially from the expectations set out herein. For additional information with respect to risks and other factors which could occur, see OpenText's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other securities filings with the SEC and other securities regulators. Unless otherwise required by applicable securities laws, OpenText disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Copyright © 2024 OpenText. All Rights Reserved. Trademarks owned by OpenText. One or more patents may cover this product(s). For more information, please visit https://www.opentext.com/patents .

OTEX-G

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/coroplast-group-partners-with-opentext-to-meet-polands-e-invoicing-mandates-302103348.html

SOURCE Open Text Corporation

News Provided by PR Newswire via QuoteMedia

OTEX:CA
The Conversation (0)
Woman watches child wearing headphones use tablet.

AI and Mobile Tech Offer Game-changing Shift in Autism Diagnosis

The convergence of artificial intelligence (AI) and mobile technology is ushering in a new era of healthcare diagnostics, particularly in neurodevelopmental conditions such as autism.

This technological synergy is not only transforming patient care through early detection and intervention, but is also creating compelling investment opportunities in the rapidly expanding healthcare AI market.

Investigating this emerging medical technology sector can provide valuable insights for investors who are looking to capitalize on these early-stage innovations.

Keep reading...Show less
A microchip with an American flag on it.

Biden Admin Awards Intel US$7.9 Billion for Semiconductor Sector Growth

The Biden administration has announced a US$7.87 billion funding agreement with Intel (NASDAQ:INTC) under the CHIPS Incentives Program as part of its efforts to bolster the US semiconductor manufacturing industry.

The award represents one of the most substantial semiconductor manufacturing investments facilitated by the CHIPS for America program.

Intel plans to invest over US$90 billion in the United States by the end of the decade, enhancing the US capacity for manufacturing leading-edge semiconductors. These advanced chips are integral to crucial industries such as artificial intelligence and defense systems.

Keep reading...Show less
Tony Di Benedetto, CEO of Syntheia AI.

Syntheia CEO Tony Di Benedetto Touts AI Innovation in Customer Call Center Application

Syntheia (CSE:SYAI) is banking on artificial intelligence (AI) and machine learning to revolutionize the way companies engage with their customers, the company’s chairman and CEO, Tony Di Benedetto, said in an interview.

“We built a platform, essentially, to act as a virtual agent which integrates into call centers. It's pretty much any type of phone system (that) engages with end users and interacts with them and avoids the on-hold process,” he explained.

Di Benedetto said Syntheia’s conversational AI platform is a solution to common challenges customers encounter when calling into a service provider’s call center or customer service department.

Keep reading...Show less
NVIDIA logo.

NVIDIA Q3 Earnings: What Investors Need to Know

Tech giant Nvidia (NASDAQ:NVDA) surpassed analyst expectations in both revenue and earnings per share in its recently released fiscal Q3 2025 results, driven by sustained demand for artificial intelligence (AI) chips.

For the quarter ending October 27, Nvidia reported adjusted earnings per share of US$0.81, exceeding the consensus estimate of US$0.75, and revenue of US$35.08 billion, above the forecasted US$33.16 billion.

The results reflect a 94 percent year-over-year gain in revenue, though this marks a consecutive slowdown compared to the growth rates of the past three quarters.

Nvidia's fourth-quarter guidance further bolstered its performance narrative, with the company projecting revenue of US$37.5 billion, plus or minus 2 percent, slightly ahead of analysts’ expectations of US$37.08 billion.

Keep reading...Show less
BlinkLab

BlinkLab to Participate in the Landmark Monash University Autism/ADHD MAGNET Project

BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for neurological conditions, is pleased to announce their participation in the landmark MAGNET (Monash Autism & ADHD Genetics and Neurodevelopment) study conducted by Monash University’s School of Psychological Sciences.

Link: https://molecularautism.biomedcentral.com/articles/10.1186/s13229-021-00457-3.

Keep reading...Show less
BlinkLab

Large-Scale Study Validates and Enhances BlinkLab’s Accuracy in Detecting Autism in Children

BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism and other neurological conditions, is excited to announce results from the latest study in autism confirming high-accuracy in detecting autism in children ahead of upcoming FDA registrational study.

Keep reading...Show less

Latest Press Releases

Related News

×